Congratulations to SA Nano, an Adelaide-based startup and a recipient of pre-seed funding from the Australian National Fabrication Facility (ANFF-C).  SA Nano is developing a quick, precise, reproducible and affordable device to make lipid nanoparticles, a carrier of next generation medicines, including mRNA vaccines. The team used this investment to commission an independent market analysis and go‑to‑market strategy to validate SA Nano’s commercial opportunity and inform pricing, sales channels and near‑term growth, alongside support for the initial manufacturing pathway.